直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • 実績

特許明細書作成及び出願手続

About

イノベーションを資産に変える

強力な特許ポートフォリオを構築するためには、戦略的なプランが重要です。特許が争われた場合、その厳しさに耐えて資産として残るのか、それとも負債となるのか。

弊所は、クライアントの利益とインストラクションを常に最優先に考え、戦略的に特許出願を起草・処理する専門家を育成しています。また、弊所弁護士は、訴訟や無効審判の経験も有しているため、異議申立だけでなく、権利行使も視野に入れた出願手続きを行うことで、最高品質の仕事を提供することができます。

弊所の特許実務には、ベテランの専門家だけでなく、比較的低い請求率で、技術や実務の経験が豊富なチームメンバーも含まれています。弁護士、弁理士、技術専門家は、科学や工学のバックグラウンドを持ち、その多くが技術分野で上級学位を取得し、業界経験を持っています。発明発掘・発明開示の段階から、クライアントの科学的貢献者と協力し、開発された発明の境界を設定し、その範囲を定義することで、付加価値を高めることに努めています。また、特許出願プロセスにおいて、クライアントの発明の成果を効果的に伝えることを重視しています。

世界的な保護のための欧州、英国、米国でのコーディネート

弊所 専門家は、欧州特許庁(EPO)、英国知的財産庁(UKIPO)、米国特許商標庁(USPTO)において、年間約 3,500 件の特許出願を行い、実務を担当しています。また、特許協力条約(PCT)にも基づいて出願しています。問題となる技術は、半導体、医療機器、化学、金属、医薬品、バイオテクノロジー、工業生産、ロボット工学、家電、コンピュータソフトウェア、ビジネス方法など、ほぼすべての産業分野に及んでいます。

欧州、英国、米国の特許専門家は、クライアントの特許ポートフォリオを戦略的かつコスト効率よくコーディネートするために、隣り合わせで仕事をしています。彼らは、特許保護を最大化し、外国出願と実務に関連するコストを最小化するために、十分に調整された、一貫性のある、包括的なグローバル実務戦略を提供します。

Everyone in this practice

実績

Comprehensive patent transactions and strategic counseling for one of the largest pharmaceutical companies in the world

Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.

Global prosecution and portfolio management for major pharmaceutical company

Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client.  The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.

Patent protection for innovative golfing technology

Finnegan assists Acushnet Company, a leading manufacturer of golf equipment, clothing, and accessories, with the development and protection of its patent portfolio through strategic patent drafting and prosecution across a variety of technologies.

Patent services for leading electric flying taxi company Archer Aviation Inc.

Finnegan assists Archer Aviation, a leading urban air mobility company responsible for designing, developing, manufacturing, and operating electric vertical takeoff and landing aircrafts to carry passengers, with matters related to patent application drafting and global prosecution. We also provide patent counseling services.

Patent drafting and prosecution for CentralSquare’s AI technologies

Finnegan is proud to partner with CentralSquare in developing and protecting its mission-critical software and technology solutions for public sector agencies, including those serving public safety and public administration. Our team has led the drafting and prosecution of a broad portfolio of artificial intelligence (AI)-related patent applications, advancing CentralSquare’s innovations across emergency services and municipal operations. These AI technologies accelerate emergency response, streamline workflows, and strengthen data-driven decision-making for agencies and the communities they serve.

 

Working closely with CentralSquare’s inventors and in-house counsel, we ensure every application captures the technical depth of the invention while aligning with CentralSquare’s strategic goals. We prioritize clarity, enforceability, and foresight—refining claims, anticipating examiner challenges, and crafting robust Office Action responses. By anticipating industry trends in AI and preparing forward-looking applications, Finnegan positions CentralSquare’s innovations not only to be protected, but to drive lasting impact in public safety and beyond.

Patent portfolio and licensing support for AI developer Megagon Labs

Finnegan supports Megagon Labs with developing its patent portfolio directed to cutting edge artificial intelligence (AI) technologies and assists with open-source licensing matters.

More

Insights

Conference

2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

IP Updates

PIER Pilot Program - Synopsis

April 09, 2026

Articles

Why Fashion Brands are Doubling Down on US Utility Patents

Why Fashion Brands are Doubling Down on US Utility Patents

March 10, 2026

Webinar

What’s Working at the PTAB Now: Strategies for Petitioners and Patent Owners

March 4, 2026

Webinar

Conference

American Intellectual Property Law Association – Delegation to the United Arab Emirates

February 8-12, 2026

Dubai

Articles

Different from U.S. Concepts of POSITA/PHOSITA, Proving “Common General Knowledge” Under German and the EPC Law: Why Proving Common General Knowledge Matters—and Why It’s Harder Than It Looks

December 1, 2025

More

最新情報

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Commentary

Litigation Leaders: Finnegan’s Jennifer Roscetti on the Advantages of Being Fully Focused on IP

April 6, 2026

Award/Ranking

Finnegan Shortlisted for Eight LSPN Awards

March 2, 2026

Award/Ranking

Finnegan Nominated for Global Firm of the Year at the 2026 Managing IP EMEA Awards

February 17, 2026

Commentary

Design Patent Dissent Highlights Frustration Over Subjectivity

February 11, 2026

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP